Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation.
Teuber. James P JP; Scissors. Rachel E RE; Brody. Matthew J MJ
Key Findings
- Active Rac1 drives heart cell enlargement (hypertrophy) both in lab dishes and in animals.
- Rac1 is needed to activate the NOX2 enzyme complex, which creates reactive oxygen species that further promote hypertrophy and damage.
- Cysteine palmitoylation of Rac1 helps dampen overactive protein kinase A signaling during acute and chronic stress.
- Targeting Rac1, NOX2, PAK1, or ASK1 shows promise in animal models for preventing or treating heart disease.
Practical Outcomes
- The findings have no direct implications for using palmitoyl‑dipeptide‑6. For biohackers, the study is mainly of academic interest about heart biology and does not provide actionable protocols or dosage guidance.
Summary
This paper reviews how a protein called Rac1 controls heart cell growth, stress responses, and rhythm problems. It does not discuss the peptide palmitoyl‑dipeptide‑6 or give any tips on using it for health or performance.
Abstract
Cardiovascular disease remains the leading cause of mortality globally and is often marked by pathologic cardiac remodeling including hypertrophy and fibrosis that promote the progression to heart failure. Ras-related C3 botulinum toxin substrate 1 (Rac1) is a Rho family small GTPase that acts as a molecular switch to regulate signaling pathways that contribute to cardiac development, hypertrophy, arrhythmia, and stress adaptation. Active Rac1 promotes cardiomyocyte hypertrophy <i>in vitro</i> and <i>in vivo</i> whereas genetic ablation or expression of inactive Rac1 protects against cardiomyocyte hypertrophy. Rac1 activates mitogen-activated protein kinase (MAPK) cascades and its canonical effector, p21-activated kinase 1 (PAK1), to promote hypertrophic gene expression. Additionally, Rac1 is a requisite accessory subunit required to activate the reactive oxygen species (ROS)-generating NADPH oxidase-2 (NOX2) enzyme complex that in turn induces hypertrophic redox signaling and oxidative damage. Cardiomyocyte Rac1 activity plays an indispensable function in cardiac adaption to elevated sympathetic activity. Rac1 cysteine palmitoylation cycling is required to attenuate hyperactive protein kinase A (PKA) signaling in response to acute adrenergic stimulation and in several models of chronic hypertrophic stress. Moreover, Rac1 and its effectors have important roles in cardiomyocyte electrophysiology and arrhythmogenesis and therapeutic approaches directly targeting Rac1, NOX2, PAK1, or apoptosis signal-regulating kinase 1 (ASK1) have shown promise in preclinical models of cardiac disease. Here, we review what is known about Rac1 signaling in cardiomyocytes, discuss how these signaling pathways can potentially be targeted for the treatment and prevention of cardiac disease, and propose areas of Rac1 signaling that warrant further exploration.
Study Information
pubmed
2025
2025-11-14T00:00:00.000Z
10.1016/j.jmccpl.2025.100826
140